APT Medical, Inc.

  • Market Cap: Large Cap
  • Industry: Miscellaneous
  • ISIN: CNE100004C45
CNY
235.59
4.54 (1.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Sep 25

  • INTEREST(9M) At CNY 1.69 MM has Grown at 7.39%
  • ROCE(HY) Lowest at 28.58%
2

With ROE of 26.46%, it has a very expensive valuation with a 15.97 Price to Book Value

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Miscellaneous

stock-summary
Market cap

CNY 32,774 Million (Large Cap)

stock-summary
P/E

60.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.52%

stock-summary
Debt Equity

-0.46

stock-summary
Return on Equity

25.15%

stock-summary
Price to Book

10.97

Revenue and Profits:
Net Sales:
704 Million
(Quarterly Results - Mar 2026)
Net Profit:
226 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.45%
0%
-0.45%
6 Months
-17.37%
0%
-17.37%
1 Year
-40.96%
0%
-40.96%
2 Years
-57.47%
0%
-57.47%
3 Years
-33.04%
0%
-33.04%
4 Years
22.88%
0%
22.88%
5 Years
-16.46%
0%
-16.46%

APT Medical, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
33.76%
EBIT Growth (5y)
52.38%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.82
Tax Ratio
12.77%
Dividend Payout Ratio
17.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
57.39%
ROE (avg)
18.28%

Valuation key factors

Factor
Value
P/E Ratio
60
Industry P/E
Price to Book Value
15.97
EV to EBIT
55.70
EV to EBITDA
48.97
EV to Capital Employed
27.17
EV to Sales
19.29
PEG Ratio
NA
Dividend Yield
0.38%
ROCE (Latest)
48.77%
ROE (Latest)
26.46%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -1.73% vs 9.62% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 17.06% vs -1.53% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "704.10",
          "val2": "716.50",
          "chgp": "-1.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "255.30",
          "val2": "246.80",
          "chgp": "3.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.50",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.00",
          "val2": "-0.20",
          "chgp": "600.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "225.80",
          "val2": "192.90",
          "chgp": "17.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "362.60%",
          "val2": "306.20%",
          "chgp": "5.64%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 25.32% vs 24.87% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.71% vs 26.07% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,557.90",
          "val2": "2,041.10",
          "chgp": "25.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "995.00",
          "val2": "797.20",
          "chgp": "24.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "2.40",
          "chgp": "-16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.50",
          "val2": "-16.70",
          "chgp": "102.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "807.70",
          "val2": "658.20",
          "chgp": "22.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "344.90%",
          "val2": "346.00%",
          "chgp": "-0.11%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
704.10
716.50
-1.73%
Operating Profit (PBDIT) excl Other Income
255.30
246.80
3.44%
Interest
0.50
0.50
Exceptional Items
1.00
-0.20
600.00%
Consolidate Net Profit
225.80
192.90
17.06%
Operating Profit Margin (Excl OI)
362.60%
306.20%
5.64%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -1.73% vs 9.62% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 17.06% vs -1.53% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
2,557.90
2,041.10
25.32%
Operating Profit (PBDIT) excl Other Income
995.00
797.20
24.81%
Interest
2.00
2.40
-16.67%
Exceptional Items
0.50
-16.70
102.99%
Consolidate Net Profit
807.70
658.20
22.71%
Operating Profit Margin (Excl OI)
344.90%
346.00%
-0.11%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 25.32% vs 24.87% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 22.71% vs 26.07% in Dec 2024

stock-summaryCompany CV
About APT Medical, Inc. stock-summary
stock-summary
APT Medical, Inc.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available